Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced its business update and financial results for the first nine months of 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback